To treat or not to treat: HER2 equivocal is the matter!
Sign Up to like & getrecommendations! Published in 2018 at "Translational cancer research"
DOI: 10.21037/16010
Abstract: With the introduction of the 2013 American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) guidelines for human epidermal growth factor receptor type 2 (HER2) testing, some authors noticed an increase in equivocal HER2… read more here.
Keywords: her2 equivocal; treat; treat treat; equivocal matter ... See more keywords